Abstract:Structure-based drug design (SBDD) utilizes the three-dimensional geometry of proteins to identify potential drug candidates. Traditional methods, grounded in physicochemical modeling and informed by domain expertise, are resource-intensive. Recent developments in geometric deep learning, focusing on the integration and processing of 3D geometric data, coupled with the availability of accurate protein 3D structure predictions from tools like AlphaFold, have greatly advanced the field of structure-based drug design. This paper systematically reviews the current state of geometric deep learning in SBDD. We first outline foundational tasks in SBDD, detail prevalent 3D protein representations, and highlight representative predictive and generative models. We then offer in-depth reviews of each key task, including binding site prediction, binding pose generation, \emph{de novo} molecule generation, linker design, and binding affinity prediction. We provide formal problem definitions and outline each task's representative methods, datasets, evaluation metrics, and performance benchmarks. Finally, we summarize the current challenges and future opportunities: current challenges in SBDD include oversimplified problem formulations, inadequate out-of-distribution generalization, a lack of reliable evaluation metrics and large-scale benchmarks, and the need for experimental verification and enhanced model understanding; opportunities include leveraging multimodal datasets, integrating domain knowledge, building comprehensive benchmarks, designing criteria based on clinical endpoints, and developing foundation models that broaden the range of design tasks. We also curate \url{<a class="link-external link-https" href="https://github.com/zaixizhang/Awesome-SBDD" rel="external noopener nofollow">this https URL</a>}, reflecting ongoing contributions and new datasets in SBDD.

Structure-based drug design with geometric deep learning

Geometric deep learning methods and applications in 3D structure-based drug design

Geometric Deep Learning for Structure-Based Ligand Design

A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design

Geometric Deep Learning for Drug Discovery

Deep Learning in Structure-Based Drug Design

Structure-based drug discovery with deep learning

Geometric Deep Learning on Molecular Representations

Structure-based <i>de novo</i> drug design using 3D deep generative models

De Novo Structure-Based Drug Design Using Deep Learning

Learning to design drug-like molecules in three-dimensional space using deep generative models

Fragment-Based Ligand Generation Guided By Geometric Deep Learning On Protein-Ligand Structure

Deep Learning with Geometry-Enhanced Molecular Representation for Augmentation of Large-Scale Docking-Based Virtual Screening.

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design

Accurate Protein-Ligand Complex Structure Prediction using Geometric Deep Learning

Structure-based protein design with deep learning

Deep Machine Learning for Computer-Aided Drug Design

One-step Structure Prediction and Screening for Protein-Ligand Complexes using Multi-Task Geometric Deep Learning

Advances in Deep Learning-Based 3D Molecular Generative Models

Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review